Core I - The CFAR International Core facilitates collaborative HIV/AIDS research activities involving CFAR members and their international colleagues by providing logistical, administrative and technical support;strategic planning;and seed funding.
The specific AIMS of the CFAR International Core are as follows: 1. Enhance existing collaborations and facilitate new ones between the CFAR research community and investigators working in resource-limited settings. 2. Facilitate the development of preliminary data in resource-limited settings to support more extensive externally funded research projects and programs. 3. Create opportunities for international researchers based in resource-limited settings to gain first-rate technical skills and establish professional connections with CFAR investigators. The International Core provides centralized administrative and logistical support to CFAR members to reduce delays in launching international research projects. Our International Pilot grants provide seed funds to foreign investigators in collaboration with CFAR members for research leading to more extensive investigations. Our Visiting Researchers and Travel grant programs facilitate the exchange of scholars between UCSD and institutions in our target countries. We organize and host an Annual Research Day to showcase international research undertaken by CFAR members and their foreign collaborators. Our Research Day increases the visibility of our CFAR's international research and helps disseminate research that is timely and topical to the San Diego HIV/AIDS research community.

Public Health Relevance

Two-thirds of the HIV pandemic is centered in Africa, 15% in Asia, and <5% in North America. The UCSD CFAR International Core supports research and training opportunities for foreign researchers in 7 middle and low-income countries to improve their capacity to respond to their local HIV epidemics, and to generate preliminary data for publications and proposals in partnership with CFAR collaborators.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI036214-20
Application #
8648961
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2014-04-01
Budget End
2015-03-31
Support Year
20
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Prakash, Katya; Gianella, Sara; Dubé, Karine et al. (2018) Willingness to participate in HIV research at the end of life (EOL). PLoS One 13:e0199670
Fraser, Hannah; Mukandavire, Christinah; Martin, Natasha K et al. (2018) Modelling the impact of a national scale-up of interventions on hepatitis C virus transmission among people who inject drugs in Scotland. Addiction 113:2118-2131
Macal, Monica; Jo, Yeara; Dallari, Simone et al. (2018) Self-Renewal and Toll-like Receptor Signaling Sustain Exhausted Plasmacytoid Dendritic Cells during Chronic Viral Infection. Immunity 48:730-744.e5
Papasavvas, Emmanouil; Lada, Steven M; Joseph, Jocelin et al. (2018) Analytical ART interruption does not irreversibly change pre-interruption levels of cellular HIV. AIDS :
Wertheim, Joel O; Murrell, Ben; Mehta, Sanjay R et al. (2018) Growth of HIV-1 Molecular Transmission Clusters in New York City. J Infect Dis 218:1943-1953
Dubé, Karine; Luter, Stuart; Lesnar, Breanne et al. (2018) Use of 'eradication' in HIV cure-related research: a public health debate. BMC Public Health 18:245
Bengtson, Angela M; Pence, Brian W; Eaton, Ellen F et al. (2018) Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antivir Ther 23:363-372
Dubé, Karine; Gianella, Sara; Concha-Garcia, Susan et al. (2018) Ethical considerations for HIV cure-related research at the end of life. BMC Med Ethics 19:83
Chaillon, Antoine; Gianella, Sara; Lada, Steven M et al. (2018) Size, Composition, and Evolution of HIV DNA Populations during Early Antiretroviral Therapy and Intensification with Maraviroc. J Virol 92:
Letendre, Scott; Bharti, Ajay; Perez-Valero, Ignacio et al. (2018) Higher Anti-Cytomegalovirus Immunoglobulin G Concentrations Are Associated With Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy. Clin Infect Dis 67:770-777

Showing the most recent 10 out of 921 publications